ESR1 and breast carcinoma: In addition, we carried out survival analyses of ER + and ER- patients separately to investigate if expression of our candidate genes is associated with ER receptor expression in breast cancer patients; the data indicates that the expression of MIR124 is independent of estrogen receptor (ER + or ER-) status in breast cancer patients (Fig. 5C).